UK clears Janssen-Cilag’s drug for Crohn’s disease, ulcerative colitis
HQ Team May 19, 2025: The UK’s Medicines and Healthcare products Regulatory Agency has approved Janssen-Cilag Limited’s guselkumab (Tremfya) to treat Crohn’s disease.
Drugs
Health
Pharma
Drugs
Health
Medical
Eli Lilly’s Omvoh gains FDA approval for treating Crohn’s disease
HQ Team The US Food and Drug Administration (FDA) has approved Eli Lilly’s Omvoh (mirikizumab-mrkz) for the treatment of moderately to severely active.
Drugs
Health
Pharma
Eli Lilly to buy Morphic for $3.2 b in cash to expand integrin therapies
Eli Lilly and Company will acquire biopharmaceutical firm, Morphic Holding Inc., for $3.2 billion in cash, giving it access to a molecule inhibitor.
Drugs
Health
Pharma
Bristol’s oral drug to treat Crohn’s disease fails remission test
HQ Team March 29, 2024: Bristol Myers Squibb’s final stage clinical trials for its Zeposia oral drug, to treat moderate to severe Crohn’s.
Drugs
Health
Pharma
Eli Lilly late-stage trial drug for Crohn’s disease meets testing goals
HQ Team October 13, 2023: Eli Lilly and Company announced its experimental drug for treating severe Crohn’s disease met secondary targets in efficacy.